These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19844638)

  • 1. The impact of genomics on the exploitation of the myxobacterial secondary metabolome.
    Wenzel SC; Müller R
    Nat Prod Rep; 2009 Nov; 26(11):1385-407. PubMed ID: 19844638
    [No Abstract]   [Full Text] [Related]  

  • 2. Myxobacterial natural product assembly lines: fascinating examples of curious biochemistry.
    Wenzel SC; Müller R
    Nat Prod Rep; 2007 Dec; 24(6):1211-24. PubMed ID: 18033576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chapter 3. Discovering natural products from myxobacteria with emphasis on rare producer strains in combination with improved analytical methods.
    Garcia RO; Krug D; Müller R
    Methods Enzymol; 2009; 458():59-91. PubMed ID: 19374979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomics-Guided Exploitation of Lipopeptide Diversity in Myxobacteria.
    Burgard C; Zaburannyi N; Nadmid S; Maier J; Jenke-Kodama H; Luxenburger E; Bernauer HS; Wenzel SC
    ACS Chem Biol; 2017 Mar; 12(3):779-786. PubMed ID: 28128551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of myxobacterial secondary metabolism goes molecular.
    Bode HB; Müller R
    J Ind Microbiol Biotechnol; 2006 Jul; 33(7):577-88. PubMed ID: 16491362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic and Biosynthetic Diversity in Marine Myxobacteria.
    Gemperlein K; Zaburannyi N; Garcia R; La Clair JJ; Müller R
    Mar Drugs; 2018 Sep; 16(9):. PubMed ID: 30189599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis and Total Synthesis of Pyrronazol B: a Secondary Metabolite from Nannocystis pusilla.
    Witte SNR; Hug JJ; Géraldy MNE; Müller R; Kalesse M
    Chemistry; 2017 Nov; 23(63):15917-15921. PubMed ID: 28944573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomics of secondary metabolite production by Pseudomonas spp.
    Gross H; Loper JE
    Nat Prod Rep; 2009 Nov; 26(11):1408-46. PubMed ID: 19844639
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhypyrazinones A and B, Pyrazinone Natural Products from a Marine-Derived Myxobacterium
    Zhang F; Braun DR; Rajski SR; DeMaria D; Bugni TS
    Mar Drugs; 2019 Dec; 17(12):. PubMed ID: 31842310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biosynthetic potential of myxobacteria and their impact in drug discovery.
    Wenzel SC; Müller R
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):220-30. PubMed ID: 19333867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myxing it up to study chondramides.
    Donadio S
    Chem Biol; 2006 Jun; 13(6):560-1. PubMed ID: 16793512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between the role, sequence conservation, genomic location and severity of phenotype in myxobacterial developmental genes.
    Evans AR; Whitworth DE
    FEMS Microbiol Lett; 2010 Nov; 312(1):40-5. PubMed ID: 20807238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and Biosynthesis of Crocagins: Polycyclic Posttranslationally Modified Ribosomal Peptides from Chondromyces crocatus.
    Viehrig K; Surup F; Volz C; Herrmann J; Abou Fayad A; Adam S; Köhnke J; Trauner D; Müller R
    Angew Chem Int Ed Engl; 2017 Jun; 56(26):7407-7410. PubMed ID: 28544148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyxipyrrolones: Structure Elucidation and Biosynthesis of Cytotoxic Myxobacterial Metabolites.
    Kjaerulff L; Raju R; Panter F; Scheid U; Garcia R; Herrmann J; Müller R
    Angew Chem Int Ed Engl; 2017 Aug; 56(32):9614-9618. PubMed ID: 28590072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myxobacteria--'microbial factories' for the production of bioactive secondary metabolites.
    Wenzel SC; Müller R
    Mol Biosyst; 2009 Jun; 5(6):567-74. PubMed ID: 19462013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A brief tour of myxobacterial secondary metabolism.
    Weissman KJ; Müller R
    Bioorg Med Chem; 2009 Mar; 17(6):2121-36. PubMed ID: 19109025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis of phenylnannolone A, a multidrug resistance reversal agent from the halotolerant myxobacterium Nannocystis pusilla B150.
    Bouhired SM; Crüsemann M; Almeida C; Weber T; Piel J; Schäberle TF; König GM
    Chembiochem; 2014 Mar; 15(5):757-65. PubMed ID: 24677362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the Myxochelin Natural Product Family by Nicotinic Acid Containing Congeners.
    Frank NA; Széles M; Akone SH; Rasheed S; Hüttel S; Frewert S; Hamed MM; Herrmann J; Schuler SMM; Hirsch AKH; Müller R
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlating chemical diversity with taxonomic distance for discovery of natural products in myxobacteria.
    Hoffmann T; Krug D; Bozkurt N; Duddela S; Jansen R; Garcia R; Gerth K; Steinmetz H; Müller R
    Nat Commun; 2018 Feb; 9(1):803. PubMed ID: 29476047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural products from myxobacteria: novel metabolites and bioactivities.
    Herrmann J; Fayad AA; Müller R
    Nat Prod Rep; 2017 Feb; 34(2):135-160. PubMed ID: 27907217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.